Extended-release morphine

From WikiMD's WELLNESSPEDIA

Chemical structure of morphine

Extended-release morphine is a formulation of the opioid analgesic morphine designed to release the active ingredient slowly over time, providing prolonged pain relief. It is commonly used in the management of chronic pain conditions where continuous opioid therapy is necessary.

Pharmacology[edit]

Extended-release morphine works by binding to opioid receptors in the central nervous system, which include the brain and spinal cord. This binding action alters the perception of pain and emotional response to pain. The extended-release formulation allows for a steady release of morphine into the bloodstream, maintaining therapeutic levels over an extended period, typically 12 to 24 hours.

Indications[edit]

Extended-release morphine is indicated for the management of severe pain that requires continuous, around-the-clock opioid treatment and for which alternative treatment options are inadequate. It is not intended for use on an as-needed basis for pain that is not constant.

Administration[edit]

Extended-release morphine is available in various forms, including oral tablets and capsules. It is important that these formulations are swallowed whole and not crushed, chewed, or dissolved, as this can lead to a rapid release of morphine, increasing the risk of overdose.

Side Effects[edit]

Common side effects of extended-release morphine include constipation, nausea, vomiting, drowsiness, and dizziness. Serious side effects can include respiratory depression, hypotension, and addiction. Patients should be monitored for signs of opioid overdose, such as extreme drowsiness, slow breathing, or loss of consciousness.

Contraindications[edit]

Extended-release morphine is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma, and in those with known hypersensitivity to morphine. It should be used with caution in patients with head injury, seizure disorders, and hepatic impairment.

Related pages[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Extended-release_morphine&oldid=6626188"